Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

850 public trials 221 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Recruiting

To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

NCT07447986

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Xiamen University Affiliated Zhongshan Hospital Xiamen, Fujian, China
View all 41 locations
View Trial Details
Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details
Recruiting

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

NCT07355218

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Cutaneous Lupus Erythematosus, +7 more
Locations
  • Inland Rheumatology Clinical Trials, Inc. Upland, California, United States
  • Omega Research Debary, LLC DeBary, Florida, United States
  • South Florida Rheumatology Hollywood, Florida, United States
  • GTL Medical And Research Group Miami, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

NCT07570862

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Miami Dermatology and Laser Research Miami, Florida, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions